logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Galena Biopharma Inc.

Galena Biopharma Inc. (GALE)

Follow

Details

Wall

Profile


Galena Biopharma Inc is a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics.

Issuer Information

Exchange: NASDAQ
Market Cap: 202816574
CEO: Mark J. Ahn
Employees: 12
Issuer Type: CS
Auditor: BDO USA, LLP
Last Audit: UQ
CIK: 1390478
Sector: Healthcare
Industry: Biotechnology
Sub-Industry: Biotechnology
NAICS: Pharmaceutical Preparation Manufacturin (325412)
SIC: 2834
Last earning call url:
Slideshare slide url:

Contact Information

Main phone: +1 855 855-4253
Address: 310 N. State Street
Address 2: Suite 208
State: OR
City / Town: Lake Oswego
Country: USA
Postal Code: 97034
Fax:

Videos

No public videos available.

Blog

No Result Found.

News

Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our…
Galena Biopharma Inc. (GALE) was among the biggest gainers on the Russell 2000 for October 16 as the stock popped 10.92% to $1.93, representing a gain of $0.19 per share.…
Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our…
Galena Biopharma Inc. (GALE) was among the biggest gainers on the Russell 2000 for October 14 as the stock popped 5.06% to $1.66, representing a gain of $0.08 per share.…
Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our…
The world of small-cap health care investing is one of huge booms and major busts. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to…
Galena Biopharma Inc. (GALE) was one of the Russell 2000's biggest losers for October 13 as the stock slid 7.6% to $1.58, a loss of $0.13 per share. Starting at…
Galena Biopharma Inc. (GALE) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $1.72, Galena Biopharma Inc. dropped to $1.56…
Galena Biopharma Inc. (GALE) was one of the Russell 2000's biggest losers for October 10 as the stock slid 5.52% to $1.71, a loss of $0.1 per share. Starting at…
Galena Biopharma Inc. (GALE) was one of the Russell 2000's biggest losers for October 7 as the stock slid 6.09% to $1.85, a loss of $0.12 per share. Starting at…

Trending

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.